HELP Study Extension: An open-label study to evaluate the long-term safety and efficacy of DX-2930 for prevention against acute attacks of hereditary angioedema (HAE)
Clinical Trial Grant
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Dyax Corporation
Start Date
January 1, 2017
End Date
February 29, 2020
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Dyax Corporation
Start Date
January 1, 2017
End Date
February 29, 2020